Demystifying the Mammogram Controversy

The U.S. Preventive Services Tasks Force caused national uproar in November 2009 when it recommended fewer mammograms for women.

HER2+ Breast Cancers Recur More Often

Recent studies may give reason for doctors to presribe Herceptin for HER2-positive breast tumors smaller than 6mm.